Financial Information
Financial Highlights (Consolidated)
(Million yen)
| FYE Mar. 2019 | FYE Mar. 2020 | FYE Mar. 2021 | FYE Mar. 2022 | FYE Mar. 2023 | |
|---|---|---|---|---|---|
| Net Sales | 58,059 | 58,569 | 57,578 | 58,169 | 63,740 |
| Operating profit | 1,462 | 2,314 | 2,127 | 980 | 724 |
| Ordinary Income | 1,520 | 2,672 | 2,013 | 1,126 | 586 |
| Net Income | 1,160 | 1,977 | 1,736 | 826 | 281 |
| Total Assets* | 67,320 | 66,567 | 69,085 | 71,971 | 74,407 |
| Net Assets | 31,900 | 32,470 | 34,993 | 37,093 | 38,700 |
| Equity Ratio (%)* | 47.2 | 48.6 | 50.4 | 51.4 | 51.8 |
| ROE (%) | 3.7 | 6.2 | 5.2 | 2.3 | 0.7 |
| ROA (%) | 2.3 | 4.0 | 3.0 | 1.6 | 0.8 |
| BPS (Yen) | 1,303.08 | 1,326.12 | 1,426.75 | 1,512.77 | 1,575.95 |
| EPS (Yen) | 47.59 | 81.12 | 71.13 | 33.83 | 11.50 |
* The Company applied "Partial Amendments to Accounting Standard for Tax Effect Accounting" ( Corporate Accounting Standard No. 28, February 16, 2018) beginning in the fiscal year ending March 31, 2019.
Cash flow trends
(Million yen)
| FYE Mar. 2019 | FYE Mar. 2020 | FYE Mar. 2021 | FYE Mar. 2022 | FYE Mar. 2023 | |
|---|---|---|---|---|---|
| Cash flows from operating activities | 4,353 | 3,565 | 3,739 | 4,399 | 2,485 |
| Cash flows from investing activities | △ 3,074 | △ 3,340 | △ 3,251 | △ 3,677 | △ 3,691 |
| Cash flows from financing activities | △ 1,229 | △ 1,187 | △ 535 | △ 499 | 525 |
| Cash and cash equivalents at end of period | 7,216 | 6,008 | 6,222 | 6,810 | 6,325 |
Other data
(Million yen)
| FYE Mar. 2019 | FYE Mar. 2020 | FYE Mar. 2021 | FYE Mar. 2022 | FYE Mar. 2023 | |
|---|---|---|---|---|---|
| R&D expense | 1,515 | 1,417 | 1,600 | 1,531 | 1,318 |
| Capital expenditures | 2,988 | 2,844 | 2,823 | 3,724 | 3,071 |
| Depreciation expense | 3,044 | 3,160 | 3,242 | 3,345 | 3,576 |
